Q2 2026 13F · SEC CIK 2010204
BlackBarn Capital Partners LP
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $402.2M
- Reported positions
- 17
- Top holdings a year, 3 yrs
- +25.8%
- Assets under management
- $1.2B
BlackBarn Capital Partners LP is a hedge fund that reported 17 positions worth $402.2M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Roivant Sciences Ltd (ROIV, 17.6%), Privia Health Group Inc (PRVA, 10.1%), Diversified Healthcare Tr (DHC, 9.4%). A portfolio copying its top holdings returned 25.8% a year over the last 3 years, against 18.8% for the S&P 500.
BlackBarn Capital Partners LP holdings all 17 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| ROIVRoivant Sciences Ltd | 17.6% | -12.5% | $70.8M |
| PRVAPrivia Health Group Inc | 10.1% | +0.0% | $40.8M |
| DHCDiversified Healthcare Tr | 9.4% | -15.3% | $37.9M |
| NEENextera Energy Inc | 7.3% | +0.0% | $29.4M |
| NIQNiq Global Intelligence PLC | 6.8% | +40.0% | $27.2M |
| UNHUnitedhealth Group Inc | 6.7% | — | $27.0M |
| NXPINxp Semiconductors N V | 6.3% | +50.0% | $25.3M |
| VKTXViking Therapeutics Inc | 5.8% | -3.5% | $23.4M |
| MHMcgraw Hill Inc | 5.8% | +17.3% | $23.2M |
| AMRXAmneal Pharmaceuticals Inc | 5.6% | -21.2% | $22.5M |
| VGVenture Global Inc | 4.8% | — | $19.5M |
| AZULAzul S A | 3.8% | — | $15.1M |
| OXYOccidental Pete Corp | 3.0% | — | $12.1M |
| ABUSArbutus Biopharma Corp | 3.0% | +0.0% | $12.0M |
| 13057Q305California Res Corp | 2.3% | — | $9.3M |
| CCOICogent Comm Holdings Inc Com New | 0.9% | -50.0% | $3.5M |
| SEATVivid Seats Inc | 0.8% | +0.0% | $3.3M |
What BlackBarn Capital Partners LP bought and sold in Q2 2026, against Q1 2026.
New positions
- UNH Unitedhealth Group Inc6.7% of 13F
- VG Venture Global Inc4.8% of 13F
- AZUL Azul S A3.8% of 13F
- OXY Occidental Pete Corp3.0% of 13F
- California Res Corp2.3% of 13F
Added to
- NXPI Nxp Semiconductors N V+50.0% shares
- NIQ Niq Global Intelligence PLC+40.0% shares
- MH Mcgraw Hill Inc+17.3% shares
Reduced
- CCOI Cogent Comm Holdings Inc Com New-50.0% shares
- AMRX Amneal Pharmaceuticals Inc-21.2% shares
- DHC Diversified Healthcare Tr-15.3% shares
- ROIV Roivant Sciences Ltd-12.5% shares
Sold out
- VECO Veeco Instrs Inc Delwas 10.2%
- GBTG Global Business Travel Groupwas 3.4%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +80.8% /yr
- S&P 500 +20.1%
- 3 years
- +25.8% /yr
- S&P 500 +18.8%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $402.2M | 17 |
| Q1 2026 | $332.4M | 14 |
| Q4 2025 | $278.9M | 11 |
| Q3 2025 | $306.4M | 15 |
| Q2 2025 | $301.8M | 20 |
| Q1 2025 | $292.8M | 18 |
| Q4 2024 | $254.1M | 15 |
| Q3 2024 | $230.1M | 18 |
| Q2 2024 | $194.0M | 17 |
| Q1 2024 | $173.0M | 21 |
| Q4 2023 | $151.4M | 17 |
Questions about BlackBarn Capital Partners LP's portfolio
What stocks does BlackBarn Capital Partners LP own?
BlackBarn Capital Partners LP's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 17 positions worth $402.2M. The largest are Roivant Sciences Ltd (ROIV) at 17.6%, Privia Health Group Inc (PRVA) at 10.1%, Diversified Healthcare Tr (DHC) at 9.4%, Nextera Energy Inc (NEE) at 7.3% and Niq Global Intelligence PLC (NIQ) at 6.8%.
What did BlackBarn Capital Partners LP buy last quarter?
In Q2 2026, BlackBarn Capital Partners LP added a new position in Unitedhealth Group Inc (UNH), a new position in Venture Global Inc (VG), a new position in Azul S A (AZUL), a new position in Occidental Pete Corp (OXY), a new position in California Res Corp, Nxp Semiconductors N V (NXPI) (+50.0% shares), Niq Global Intelligence PLC (NIQ) (+40.0% shares) and Mcgraw Hill Inc (MH) (+17.3% shares), compared with its Q1 2026 filing.
What did BlackBarn Capital Partners LP sell last quarter?
In Q2 2026, BlackBarn Capital Partners LP sold all of Veeco Instrs Inc Del (VECO), sold all of Global Business Travel Group (GBTG), Cogent Comm Holdings Inc Com New (CCOI) (-50.0% shares), Amneal Pharmaceuticals Inc (AMRX) (-21.2% shares) and Diversified Healthcare Tr (DHC) (-15.3% shares), compared with its Q1 2026 filing.
How has BlackBarn Capital Partners LP's portfolio performed?
A portfolio copying BlackBarn Capital Partners LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +25.8% a year over the last 3 years, against +18.8% for the S&P 500. Over 1 year: +80.8% against +20.1%.
When is BlackBarn Capital Partners LP's next 13F filing due?
13F filings are due 45 days after each quarter ends. BlackBarn Capital Partners LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does BlackBarn Capital Partners LP manage?
BlackBarn Capital Partners LP reported $1.2B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $402.2M.